Literature DB >> 7843695

Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.

E Silini1, F Bono, A Cividini, A Cerino, S Bruno, S Rossi, G Belloni, B Brugnetti, E Civardi, L Salvaneschi.   

Abstract

Hepatitis C virus (HCV) infection persists for an indefinite length of time in a major proportion of patients, inducing chronic liver lesions that evolve to cirrhosis and hepatocellular carcinoma (HCC) in approximately 20% of cases. We studied HCV viremia and genotypes by reverse transcription-polymerase chain reaction (RT-PCR) in 341 consecutive anti-HCV-positive patients. Of these, 167 patients had persistently normal or near normal alanine aminotransferase (ALT) levels (fluctuations < or = 5 IU above the upper limit of normal); the remaining 174 patients presented with elevated ALT and histological evidence of chronic liver disease. Seventy percent of patients with normal ALT values had circulating HCV RNA despite the absence of biochemical indicators of liver damage and mild histological forms of chronic hepatitis were detected in most patients who underwent liver biopsy. Isolated genotype III infection was significantly more prevalent in this patient group with respect to control patients with abnormal ALT values (70% vs. 39%; P < .001). Conversely, isolated genotype II was more frequently found in patients with elevated ALT values and evidence of chronic liver disease (45% vs. 23%; P < .01) and it was progressively more represented in advanced liver disease, such as cirrhosis and HCC. Virological features of HCV infection might be associated with different clinical manifestations, suggesting a potential prognostic significance on disease outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843695

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

1.  Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population-based study.

Authors:  A R Osella; L Sonzogni; A Cavallini; L Foti; V Guerra; A Di Leo; M U Mondelli; G Misciagna; E M Silini
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio.

Authors:  S Mihm; H Hartmann; A Fayyazi; G Ramadori
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

3.  Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients.

Authors:  M G Rumi; F De Filippi; C La Vecchia; M F Donato; S Gallus; E Del Ninno; M Colombo
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Comparative evaluation of two serologic typing methods for hepatitis C virus.

Authors:  A Cerino; A Cividini; M Asti; A Lanza; E Silini; M U Mondelli
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

5.  Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.

Authors:  S Le Pogam; F Dubois; R Christen; C Raby; A Cavicchini; A Goudeau
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay.

Authors:  S Navas; I Castillo; J Martín; J A Quiroga; J Bartolomé; V Carreño
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  Prevalence of hepatitis C virus genotypes in southern Italy.

Authors:  S Cicciarello; G Borgia; J Crowell; R Ciampi; R Cerini; R Orlando; M Mainolfi; L Reynaud; M Milano; M Piazza
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

Review 8.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

9.  Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.

Authors:  C Renou; P Halfon; S Pol; P Cacoub; E Jouve; J P Bronowicki; J P Arpurt; H Rifflet; M Picon; X Causse; V Canva; J Denis; A Tran; M Bourliére; D Ouzan; A Pariente; S Dantin; L Alric; V Cartier; M Reville; S Caillat-Zucman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

10.  Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection.

Authors:  M Resti; C Azzari; F Mannelli; M Moriondo; E Novembre; M de Martino; A Vierucci
Journal:  BMJ       Date:  1998-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.